Evidence map›Paper›PMID 36051562›Full record

ArticleBeilstein journal of organic chemistry2022

New azodyrecins identified by a genome mining-directed reactivity-based screening.

Atina Rizkiya Choirunnisa, Kuga Arima, Yo Abe, Noritaka Kagaya, Kei Kudo, Hikaru Suenaga, Junko Hashimoto, Manabu Fujie, Noriyuki Satoh, Kazuo Shin-Ya and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Beilstein journal of organic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Atina Rizkiya Choirunnisa *Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.ORCID https://orcid.org/0000-0001-6594-1125
Kuga Arima *Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.ORCID https://orcid.org/0000-0002-1093-6342
Yo AbeFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.
Noritaka KagayaTechnology Research Association for Next Generation Natural Products Chemistry, Tokyo 135-0064, Japan.
Kei KudoNational Institute of Advanced Industrial Science and Technology (AIST), Tokyo 135-0064, Japan.ORCID https://orcid.org/0000-0001-7500-9462
Hikaru SuenagaNational Institute of Advanced Industrial Science and Technology (AIST), Tokyo 135-0064, Japan.
Junko HashimotoJapan Biological Informatics Consortium (JBIC), Tokyo 135-0064, Japan.
Manabu FujieOkinawa Institute of Science and Technology Graduate University, Okinawa, 904-0495, Japan.
Noriyuki SatohOkinawa Institute of Science and Technology Graduate University, Okinawa, 904-0495, Japan.
Kazuo Shin-YaNational Institute of Advanced Industrial Science and Technology (AIST), Tokyo 135-0064, Japan.
Kenichi MatsudaFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.ORCID https://orcid.org/0000-0002-9269-688X
Toshiyuki WakimotoFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.ORCID https://orcid.org/0000-0003-2917-1797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only a few azoxy natural products have been identified despite their intriguing biological activities. Azodyrecins D-G, four new analogs of aliphatic azoxides, were identified from two

Indexed as

biosynthesismethyltransferasenatural azoxidesreactivity-based screeningStreptomyces

Identifiers

PMID36051562
PMCPMC9379638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.